Siv Js Olsen1,2, Bengt Fridlund3,4,5, Leslie Sp Eide6, Karl O Hufthammer7, Karel Kj Kuiper3, Jan E Nordrehaug6,8, Elisabeth Skaar3,9, Tone M Norekvål3,5,6. 1. 1 Division of Internal Medicine, University Hospital of North Norway, Harstad, Norway. 2. 2 Department of Health and Care Sciences, The Arctic University of Norway, Harstad, Norway. 3. 3 Department of Heart Disease, Haukeland University Hospital, Bergen, Norway. 4. 4 School for Health and Welfare, Jönköping University, Sweden. 5. 5 Institute of Nursing, Faculty of Health and Social Science, Bergen University College, Norway. 6. 6 Department of Clinical Science, University of Bergen, Norway. 7. 7 Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. 8. 8 Department of Cardiology, Stavanger University Hospital, Norway. 9. 9 Kavli Research Centre for Geriatrics and Dementia, Haraldsplass Deaconess Hospital, Bergen, Norway.
Abstract
BACKGROUND: In addition to favourable results regarding mortality and morbidity it is important to identify the impact transcatheter aortic valve implantation (TAVI) has on patients' quality of life. AIMS: The aims were: (i) to describe clinical characteristics, self-reported health and quality of life in octogenarians before TAVI intervention; (ii) to determine changes in self-reported health and quality of life one month after TAVI; and (iii) to establish the clinical importance of the findings. METHODS: A prospective cohort study was conducted on consecutively enrolled octogenarians with severe aortic stenosis undergoing TAVI ( N = 65). Self-reported health and quality of life were recorded at baseline and one month later using two global questions from the World Health Organization Quality of Life Instrument Abbreviated (WHOQOL-BREF), the generic Short Form Health 12 and the disease-specific Minnesota Living with Heart Failure Questionnaire. RESULTS: One month after TAVI, WHOQOL-BREF showed that self-reported health improved moderately ( p < 0.001), while quality of life improved slightly, but not statistically significantly ( p = 0.06). There were changes in all Short Form Health 12 domains, except social functioning and role emotional. The estimated changes were 3.6 to 5.8 with large confidence intervals. The Physical Component Summary increased statistically significantly from baseline to 30 days (30.6-34.7; p = 0.02), but the Mental Component Summary did not (46.9-50.0; p = 0.13). CONCLUSION: Despite being an advanced treatment performed in a high risk population, TAVI in octogenarians improves short-term self-reported global health and generic physical health and quality of life. These patient-reported outcomes have importance, particularly in this age group.
BACKGROUND: In addition to favourable results regarding mortality and morbidity it is important to identify the impact transcatheter aortic valve implantation (TAVI) has on patients' quality of life. AIMS: The aims were: (i) to describe clinical characteristics, self-reported health and quality of life in octogenarians before TAVI intervention; (ii) to determine changes in self-reported health and quality of life one month after TAVI; and (iii) to establish the clinical importance of the findings. METHODS: A prospective cohort study was conducted on consecutively enrolled octogenarians with severe aortic stenosis undergoing TAVI ( N = 65). Self-reported health and quality of life were recorded at baseline and one month later using two global questions from the World Health Organization Quality of Life Instrument Abbreviated (WHOQOL-BREF), the generic Short Form Health 12 and the disease-specific Minnesota Living with Heart Failure Questionnaire. RESULTS: One month after TAVI, WHOQOL-BREF showed that self-reported health improved moderately ( p < 0.001), while quality of life improved slightly, but not statistically significantly ( p = 0.06). There were changes in all Short Form Health 12 domains, except social functioning and role emotional. The estimated changes were 3.6 to 5.8 with large confidence intervals. The Physical Component Summary increased statistically significantly from baseline to 30 days (30.6-34.7; p = 0.02), but the Mental Component Summary did not (46.9-50.0; p = 0.13). CONCLUSION: Despite being an advanced treatment performed in a high risk population, TAVI in octogenarians improves short-term self-reported global health and generic physical health and quality of life. These patient-reported outcomes have importance, particularly in this age group.
Entities:
Keywords:
TAVI; older people; quality of life; self-reported health; severe aortic stenosis
Authors: Leslie S P Eide; Anette H Ranhoff; Bengt Fridlund; Rune Haaverstad; Karl Ove Hufthammer; Karel K J Kuiper; Jan Erik Nordrehaug; Tone M Norekvål Journal: BMJ Open Date: 2016-10-05 Impact factor: 2.692
Authors: Marjo Jag De Ronde-Tillmans; Tom Aj de Jager; Jeannette A Goudzwaard; Nahid El Faquir; Nicolas M van Mieghem; Felix Zijlstra; Elisabeth Mwj Utens; Francesco Us Mattace-Raso; Mattie J Lenzen; Peter Pt de Jaegere Journal: J Geriatr Cardiol Date: 2018-04 Impact factor: 3.327
Authors: Marco Barbanti; Jan Baan; Mark S Spence; Fortunato Iacovelli; Gian Luca Martinelli; Francesco Saia; Alessandro Santo Bortone; Frank van der Kley; Douglas F Muir; Cameron G Densem; Marije Vis; Martijn S van Mourik; Lenka Seilerova; Claudia M Lüske; Peter Bramlage; Corrado Tamburino Journal: BMC Cardiovasc Disord Date: 2017-10-10 Impact factor: 2.298
Authors: Leslie Sp Eide; Anette H Ranhoff; Sandra Lauck; Bengt Fridlund; Rune Haaverstad; Karl Ove Hufthammer; Karel K J Kuiper; Jan Erik Nordrehaug; Tone Merete Norekvål Journal: BMJ Open Date: 2018-11-01 Impact factor: 2.692
Authors: Clare J Taylor; José M Ordóñez-Mena; Nicholas R Jones; Andrea K Roalfe; Saul G Myerson; Bernard D Prendergast; Fd Richard Hobbs Journal: Heart Date: 2021-05-24 Impact factor: 7.365